Skip to content
PubMed This is a summary of 79 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 79 referenced papers

Top Authors

Marina Colombi
University of Brescia
Marco Ritelli
University of Brescia
Nicola Chiarelli
University of Brescia
Alan J. Hakim
Ehlers-Danlos Society
Verity Pacey
Macquarie University
Clair A. Francomano
Indiana University School of Medicine
Lies Rombaut
Ghent University Hospital
Marina Venturini
University of Brescia
Raoul Engelbert
Emma Kinderziekenhuis
Nicoletta Zoppi
University of Brescia

Top Institutions

Ranked by publications Top 10 institutions
03

Indiana University School of Medicine

Indianapolis, United States

26 papers
04

Ehlers-Danlos Society

McLean, United States

21 papers

References

References (79)
  1. 1

    Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders.

    Colombi M, Dordoni C, Chiarelli N, Ritelli M

    American journal of medical genetics. Part C, Seminars in medical genetics 2015; (169C(1)):6-22 doi:10.1002/ajmg.c.31429.

    PMID: 25821090
  2. 2

    Difficulty eating and significant weight loss in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

    Baeza-Velasco C, Van den Bossche T, Grossin D, Hamonet C

    Eating and weight disorders : EWD 2016; (21(2)):175-83 doi:10.1007/s40519-015-0232-x.

    PMID: 26506923
  3. 3

    Joint Hypermobility Syndrome: Recognizing a Commonly Overlooked Cause of Chronic Pain.

    Kumar B, Lenert P

    The American journal of medicine 2017; (130(6)):640-647 doi:10.1016/j.amjmed.2017.02.013.

    PMID: 28286166
  4. 4

    Measurement properties of clinical assessment methods for classifying generalized joint hypermobility-A systematic review.

    Juul-Kristensen B, Schmedling K, Rombaut L, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2017; (175(1)):116-147 doi:10.1002/ajmg.c.31540.

    PMID: 28306223
  5. 5

    Natural history of aortic root dilation through young adulthood in a hypermobile Ehlers-Danlos syndrome cohort.

    Ritter A, Atzinger C, Hays B, et al.

    American journal of medical genetics. Part A 2017; (173(6)):1467-1472 doi:10.1002/ajmg.a.38243.

    PMID: 28436618
  6. 6

    Hypermobility, the Ehlers-Danlos syndromes and chronic pain.

    Syx D, De Wandele I, Rombaut L, Malfait F

    Clinical and experimental rheumatology 2017; (35 Suppl 107(5)):116-122.

    PMID: 28967365
  7. 7

    Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome.

    Meester JAN, Verstraeten A, Schepers D, et al.

    Annals of cardiothoracic surgery 2017; (6(6)):582-594 doi:10.21037/acs.2017.11.03.

    PMID: 29270370
  8. 8

    Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Zoppi N, Chiarelli N, Binetti S, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2018; (1864(4 Pt A)):1010-1023 doi:10.1016/j.bbadis.2018.01.005.

    PMID: 29309923
  9. 9

    Development and validation of self-reported line drawings of the modified Beighton score for the assessment of generalised joint hypermobility.

    Cooper DJ, Scammell BE, Batt ME, Palmer D

    BMC medical research methodology 2018; (18(1)):11 doi:10.1186/s12874-017-0464-8.

    PMID: 29343224
  10. 10

    Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes' Dermal Fibroblasts.

    Zoppi N, Chiarelli N, Ritelli M, Colombi M

    International journal of molecular sciences 2018; (19(4)) doi:10.3390/ijms19040982.

    PMID: 29587413
  11. 11

    Exercise and non-pharmacological treatment of POTS.

    Fu Q, Levine BD

    Autonomic neuroscience : basic & clinical 2018; (215()):20-27 doi:10.1016/j.autneu.2018.07.001.

    PMID: 30001836
  12. 12

    Hypermobile Ehlers-Danlos syndrome and pregnancy.

    Karthikeyan A, Venkat-Raman N

    Obstetric medicine 2018; (11(3)):104-109 doi:10.1177/1753495X18754577.

    PMID: 30214474
  13. 13

    Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.

    Peterson B, Coda A, Pacey V, Hawke F

    Journal of foot and ankle research 2018; (11()):59 doi:10.1186/s13047-018-0302-1.

    PMID: 30455744
  14. 14

    Anesthetic Management for Ehlers-Danlos Syndrome, Hypermobility Type Complicated by Local Anesthetic Allergy: A Case Report.

    Cesare AE, Rafer LC, Myler CS, Brennan KB

    The American journal of case reports 2019; (20()):39-42 doi:10.12659/AJCR.912799.

    PMID: 30626862
  15. 15

    Pain in hypermobile Ehlers-Danlos syndrome: New insights using new criteria.

    Bénistan K, Martinez V

    American journal of medical genetics. Part A 2019; (179(7)):1226-1234 doi:10.1002/ajmg.a.61175.

    PMID: 31075184
  16. 16

    Recognizing and Effectively Managing Hypermobility-Related Conditions.

    Russek LN, Stott P, Simmonds J

    Physical therapy 2019; (99(9)):1189-1200 doi:10.1093/ptj/pzz078.

    PMID: 31158283
  17. 17

    Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology.

    Ritelli M, Rovati C, Venturini M, et al.

    Clinical genetics 2020; (97(2)):287-295 doi:10.1111/cge.13653.

    PMID: 31600821
  18. 18

    Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective review.

    McGillis L, Mittal N, Santa Mina D, et al.

    American journal of medical genetics. Part A 2020; (182(3)):484-492 doi:10.1002/ajmg.a.61459.

    PMID: 31840928
  19. 19

    Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.

    Miller AJ, Stiles LE, Sheehan T, et al.

    Autonomic neuroscience : basic & clinical 2020; (224()):102637 doi:10.1016/j.autneu.2020.102637.

    PMID: 31954224
  20. 20

    Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.

    Lam CY, Palsson OS, Whitehead WE, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021; (19(2)):277-287.e3 doi:10.1016/j.cgh.2020.02.034.

    PMID: 32109633
  21. 21

    A new insight on postural tachycardia syndrome in 102 adults with hypermobile Ehlers-Danlos Syndrome/hypermobility spectrum disorder.

    Celletti C, Borsellino B, Castori M, et al.

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2020; (90(2)) doi:10.4081/monaldi.2020.1286.

    PMID: 32434316
  22. 22

    Cardiac involvement in classical or hypermobile Ehlers-Danlos syndrome is uncommon.

    Paige SL, Lechich KM, Tierney ESS, Collins RT

    Genetics in medicine : official journal of the American College of Medical Genetics 2020; (22(10)):1583-1588 doi:10.1038/s41436-020-0856-8.

    PMID: 32518415
  23. 23

    Validity of the self-reported five-part questionnaire as an assessment of generalized joint hypermobility in early pregnancy.

    Schlager A, Ahlqvist K, Pingel R, et al.

    BMC musculoskeletal disorders 2020; (21(1)):514 doi:10.1186/s12891-020-03524-7.

    PMID: 32746889
  24. 24

    Pelvic Girdle Pain, Hypermobility Spectrum Disorder and Hypermobility-Type Ehlers-Danlos Syndrome: A Narrative Literature Review.

    Ali A, Andrzejowski P, Kanakaris NK, Giannoudis PV

    Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9123992.

    PMID: 33317183
  25. 25

    Prevalence of joint hypermobility syndromes in pediatric postural orthostatic tachycardia syndrome.

    Boris JR, Bernadzikowski T

    Autonomic neuroscience : basic & clinical 2021; (231()):102770 doi:10.1016/j.autneu.2020.102770.

    PMID: 33388686
  26. 26

    Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome.

    Bourne KM, Sheldon RS, Hall J, et al.

    Journal of the American College of Cardiology 2021; (77(3)):285-296 doi:10.1016/j.jacc.2020.11.040.

    PMID: 33478652
  27. 27

    Practical management strategies for benign hypermobility syndromes.

    Minhas D

    Current opinion in rheumatology 2021; (33(3)):249-254 doi:10.1097/BOR.0000000000000798.

    PMID: 33741806
  28. 28

    Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

    Yew KS, Kamps-Schmitt KA, Borge R

    American family physician 2021; (103(8)):481-492.

    PMID: 33856167
  29. 29

    Multidisciplinary Treatment for Hypermobile Adolescents with Chronic Musculoskeletal Pain.

    Van Meulenbroek T, Conijn AEA, Huijnen IPJ, et al.

    Journal of rehabilitation medicine. Clinical communications 2020; (3()):1000033 doi:10.2340/20030711-1000033.

    PMID: 33884135
  30. 30

    Chronic Low Back Pain Occurring in Association With Hypermobility Spectrum Disorder and Ehlers-Danlos Syndrome.

    Eseonu KC, Payne K, Ward S, et al.

    International journal of spine surgery 2021; (15(3)):449-457 doi:10.14444/8067.

    PMID: 33963027
  31. 31

    Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.

    Bennett SE, Walsh N, Moss T, Palmer S

    Disability and rehabilitation 2022; (44(18)):5231-5240 doi:10.1080/09638288.2021.1933618.

    PMID: 34101520
  32. 32

    Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care.

    Atwell K, Michael W, Dubey J, et al.

    Journal of the American Board of Family Medicine : JABFM 2021; (34(4)):838-848 doi:10.3122/jabfm.2021.04.200374.

    PMID: 34312277
  33. 33

    Dysautonomia in the Ehlers-Danlos syndromes and hypermobility spectrum disorders-With a focus on the postural tachycardia syndrome.

    Mathias CJ, Owens A, Iodice V, Hakim A

    American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):510-519 doi:10.1002/ajmg.c.31951.

    PMID: 34766441
  34. 34

    Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Rashed ER, Ruiz Maya T, Black J, et al.

    Vascular medicine (London, England) 2022; (27(3)):283-289 doi:10.1177/1358863X211067566.

    PMID: 35000503
  35. 35

    Muscle Strength, Muscle Mass and Physical Impairment in Women with hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorder.

    Coussens M, Lapauw B, Banica T, et al.

    Journal of musculoskeletal & neuronal interactions 2022; (22(1)):5-14.

    PMID: 35234154
  36. 36

    Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.

    Thwaites PA, Gibson PR, Burgell RE

    Journal of gastroenterology and hepatology 2022; (37(9)):1693-1709 doi:10.1111/jgh.15927.

    PMID: 35750466
  37. 37

    Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes.

    Igharo D, Thiel JC, Rolke R, et al.

    European journal of neurology 2023; (30(3)):719-728 doi:10.1111/ene.15649.

    PMID: 36437696
  38. 38

    RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms.

    Ritelli M, Chiarelli N, Cinquina V, et al.

    Cells 2022; (11(24)) doi:10.3390/cells11244040.

    PMID: 36552803
  39. 39

    The role of gene encoding collagen secretion protein (SERPINH1) in the pathogenesis of a hypermobile type of Ehlers-Danlos syndrome.

    Junkiert-Czarnecka A, Pilarska-Deltow M, Bąk A, et al.

    Postepy dermatologii i alergologii 2023; (40(1)):102-106 doi:10.5114/ada.2022.124107.

    PMID: 36909907
  40. 40

    Pediatric joint hypermobility: a diagnostic framework and narrative review.

    Tofts LJ, Simmonds J, Schwartz SB, et al.

    Orphanet journal of rare diseases 2023; (18(1)):104 doi:10.1186/s13023-023-02717-2.

    PMID: 37143135
  41. 41

    Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.

    Garreth Brittain M, Flanagan S, Foreman L, Teran-Wodzinski P

    Disability and rehabilitation 2024; (46(10)):1936-1953 doi:10.1080/09638288.2023.2216028.

    PMID: 37231592
  42. 42

    Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies.

    Marelli S, Micaglio E, Taurino J, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(13)) doi:10.3390/diagnostics13132284.

    PMID: 37443678
  43. 43

    Hypermobility spectrum disorders: A review.

    Carroll MB

    Rheumatology and immunology research 2023; (4(2)):60-68 doi:10.2478/rir-2023-0010.

    PMID: 37637226
  44. 44

    Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.

    Ritelli M, Chiarelli N, Cinquina V, et al.

    American journal of medical genetics. Part A 2024; (194(2)):174-194 doi:10.1002/ajmg.a.63426.

    PMID: 37774134
  45. 45

    Childbearing with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Large International Survey of Outcomes and Complications.

    Pearce G, Bell L, Pezaro S, Reinhold E

    International journal of environmental research and public health 2023; (20(20)) doi:10.3390/ijerph20206957.

    PMID: 37887695
  46. 46

    Cardiovascular Symptoms, Dysautonomia, and Quality of Life in Adult and Pediatric Patients with Hypermobile Ehlers-Danlos Syndrome: A Brief Review.

    Hertel A, Black WR, Walton LM, et al.

    Current cardiology reviews 2024; (20(1)):e240124226070 doi:10.2174/011573403X271096231203164216.

    PMID: 38275067
  47. 47

    Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.

    Fernandez A, Jaquet M, Aubry-Rozier B, et al.

    Brain and behavior 2024; (14(2)):e3441 doi:10.1002/brb3.3441.

    PMID: 38409931
  48. 48

    Assessment of gait mechanics and muscle strength in hypermobile Ehlers Danlos Syndrome.

    Ball LN, Jacobs MV, McLouth CJ, et al.

    Clinical biomechanics (Bristol, Avon) 2024; (113()):106210 doi:10.1016/j.clinbiomech.2024.106210.

    PMID: 38412743
  49. 49

    Generalized Joint Hypermobility: A Statistical Analysis Identifies Non-Axial Involvement in Most Cases.

    Lamari MM, Lamari NM, de Medeiros MP, et al.

    Children (Basel, Switzerland) 2024; (11(3)) doi:10.3390/children11030344.

    PMID: 38539379
  50. 50

    Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.

    Pezaro S, Brock I, Buckley M, et al.

    PloS one 2024; (19(5)):e0302401 doi:10.1371/journal.pone.0302401.

    PMID: 38748660
  51. 51

    Longitudinal echocardiography in pediatric patients with hypermobile Ehlers-Danlos syndrome.

    Lahey H, Shin H, Myers K, McBride KL

    American journal of medical genetics. Part A 2024; (194(12)):e63844 doi:10.1002/ajmg.a.63844.

    PMID: 39148461
  52. 52

    Evidence for central sensitization as classified by the central sensitization inventory in patients with pain and hypermobility.

    Desai MJ, Brestle M, Jonely H

    Pain practice : the official journal of World Institute of Pain 2025; (25(1)):e13411 doi:10.1111/papr.13411.

    PMID: 39192465
  53. 53

    The Effectiveness of Conservative Interventions on Pain, Function, and Quality of Life in Adults with Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorders and Shoulder Symptoms: A Systematic Review.

    Higo A, Palmer S, Liaghat B, et al.

    Archives of rehabilitation research and clinical translation 2024; (6(3)):100360 doi:10.1016/j.arrct.2024.100360.

    PMID: 39372240
  54. 54

    Cardiovascular, autonomic symptoms and quality of life in children with hypermobile Ehlers-Danlos syndrome.

    Hertel AK, Black WR, Lytch A, et al.

    SAGE open medicine 2024; (12()):20503121241287073 doi:10.1177/20503121241287073.

    PMID: 39420997
  55. 55

    Exploring signs of central sensitization in adolescents with hypermobility Spectrum disorder or hypermobile Ehlers-Danlos syndrome.

    Schubert-Hjalmarsson E, Fasth A, Ickmans K, et al.

    European journal of pain (London, England) 2025; (29(1)):e4754 doi:10.1002/ejp.4754.

    PMID: 39529262
  56. 56

    Hypermobile Ehlers Danlos for the Primary Care Provider.

    White L, Procknow SS

    Missouri medicine 2024; (121(4)):289-296.

    PMID: 39575079
  57. 57

    Headache disorders in patients with Ehlers-Danlos syndromes and hypermobility spectrum disorders.

    Mehta D, Simmonds L, Hakim AJ, Matharu M

    Frontiers in neurology 2024; (15()):1460352 doi:10.3389/fneur.2024.1460352.

    PMID: 39582682
  58. 58

    Ehlers-Danlos Syndromes and Related Disorders: Diagnostic Challenges and the Need for an Interdisciplinary Patient Care in Germany.

    Kernich N, Peters F, Schreml J, et al.

    Dermatology (Basel, Switzerland) 2025; (241(2)):124-132 doi:10.1159/000542026.

    PMID: 39657610
  59. 59

    Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Darakjian AA, Bhutani M, Fairweather D, et al.

    Rheumatology advances in practice 2024; (8(4)):rkae134 doi:10.1093/rap/rkae134.

    PMID: 39660107
  60. 60

    Adaptive Approaches to Exercise Rehabilitation for Postural Tachycardia Syndrome and Related Autonomic Disorders.

    Ziaks L, Johnson K, Schiltz K, et al.

    Archives of rehabilitation research and clinical translation 2024; (6(4)):100366 doi:10.1016/j.arrct.2024.100366.

    PMID: 39822199
  61. 61

    HOPE for Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD)-A Pilot Randomised Controlled Trial of Feasibility, Acceptability and Appropriateness.

    Chew MT, Ilhan E, Nicholson LL, et al.

    European journal of pain (London, England) 2025; (29(6)):e70030 doi:10.1002/ejp.70030.

    PMID: 40298033
  62. 62

    AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.

    Aziz Q, Harris LA, Goodman BP, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2025; (23(8)):1291-1302 doi:10.1016/j.cgh.2025.02.015.

    PMID: 40387691
  63. 63

    Hypermobile Ehlers-Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing.

    Forghani I, See J, McGonigle WC

    Genes 2025; (16(5)) doi:10.3390/genes16050530.

    PMID: 40428350
  64. 64

    Abdominal Compression Syndromes in the Hypermobile Ehlers-Danlos Syndrome.

    Milunsky A, Milunsky JM, Hsu R

    American journal of medical genetics. Part A 2025; (197(12)):e64182 doi:10.1002/ajmg.a.64182.

    PMID: 40653826
  65. 65

    Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.

    Novak P, Systrom DM, Marciano SP, et al.

    American journal of medicine open 2025; (14()):100111 doi:10.1016/j.ajmo.2025.100111.

    PMID: 40843452
  66. 66

    Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSD.

    Fairweather D, Bruno KA, Darakjian AA, et al.

    Frontiers in medicine 2025; (12()):1594796 doi:10.3389/fmed.2025.1594796.

    PMID: 40880755
  67. 67

    KLK15 alters connective tissues in hypermobile Ehlers-Danlos syndrome.

    Gensemer C, Petrucci T, Beck T, et al.

    iScience 2025; (28(9)):113343 doi:10.1016/j.isci.2025.113343.

    PMID: 40949095
  68. 68

    Complex Genetics and Regulatory Drivers of Hypermobile Ehlers-Danlos Syndrome: Insights from Genome-Wide Association Study Meta-analysis.

    Petrucci-Nelson T, Guilhaumou S, Berrandou TE, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.09.19.25336146.

    PMID: 41001447
  69. 69

    Joint Hypermobility: An Under-Recognised Cause of Palpitations, Dizziness, and Syncope in Young Females.

    Abu Orabi Z, Thompson SE, van Vliet J, et al.

    Journal of clinical medicine 2025; (14(20)) doi:10.3390/jcm14207373.

    PMID: 41156242
  70. 70

    Compression garments in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study.

    Boulu X, Karam JD, Schmidt J

    BMC musculoskeletal disorders 2025; (26(1)):1066 doi:10.1186/s12891-025-09318-z.

    PMID: 41286814
  71. 71

    Generalized Joint Hypermobility in Adults: A Systematic Review With Meta-Analysis to Identify Data-Driven Cut-offs Using the Beighton Score.

    Tofts L, Pacey V, Williams CM, et al.

    Arthritis care & research 2026; (78(8)):987-997 doi:10.1002/acr.70017.

    PMID: 41399207
  72. 72

    Outcomes and experiences of patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders undergoing surgical interventions: a scoping review.

    Clark NL, Johnson M, Adamson J, et al.

    Rheumatology international 2026; (46(1)):29 doi:10.1007/s00296-025-06062-4.

    PMID: 41493475
  73. 73

    Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.

    Rozen TD, Bruno KA, Rozen EM, et al.

    Neurology international 2026; (18(2)) doi:10.3390/neurolint18020033.

    PMID: 41745718
  74. 74

    The Investigation and Management of the Abdominopelvic Vascular Compression Syndromes in Patients with Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder.

    Bruessel P, Govender M, Frahm-Jensen G

    Vascular health and risk management 2026; (22()):592420 doi:10.2147/VHRM.S592420.

    PMID: 41924132
  75. 75

    Multimodal Wearable and Survey Data Reveal Distinct Physiologic Profiles in Hypermobile-Ehlers Danlos Syndrome for Screening Advancements.

    Wilson D, Shilling M, Nowak T, et al.

    medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.04.01.26349981.

    PMID: 41959756
  76. 76

    2-Chloroprocaine vs. Lidocaine in a Patient With Hypermobile Ehlers-Danlos Syndrome and a History of Local Anesthetic Resistance: A Case Report.

    Dasika J, Deutch ZB, Hoefnagel AL

    Case reports in anesthesiology 2026; (2026()):8693646 doi:10.1155/cria/8693646.

    PMID: 41970145
  77. 77

    Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

    Kulin D, Holtmann G, Fairlie T, et al.

    Alimentary pharmacology & therapeutics 2026; (64(5)):574-589 doi:10.1111/apt.70856.

    PMID: 42437376
  78. 78

    Postural Orthostatic Tachycardia Syndrome (POTS): A Review.

    Chung TH, Raj SR

    JAMA 2026; (336(13)):1149-1164 doi:10.1001/jama.2026.14809.

    PMID: 42635998
  79. 79

    Headache in patients with joint hypermobility.

    Oliveira WS, Hoffmann J, Jácomo AAE, et al.

    Cephalalgia : an international journal of headache 2026; (46(8)):3331024261477381 doi:10.1177/03331024261477381.

    PMID: 42640494